NCT06736171

Post Stroke Ambulation Recovery Using Robotic Exoskeletons

Prescription of Robotic Exoskeletons for Ambulation Recovery Post Stroke

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 96 (estimated)
• Sponsor: Kessler Foundation · Academic / Other
• Sex: All
• Age: 50 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this research study is to evaluate and compare different robotic exoskeletons (RE) and identify which is most appropriate for gait training for each patient based off their specific needs. This will help guide clinicians in prescribing the appropriate RE for rehabilitation.

Detailed description

This study will systematically compare various commercially available REs and aid in identifying the appropriate devices for gait training prescription in individuals post-stroke based on their deficits. The objective of this study is to evaluate and compare the four groups (3 REs and standard of care treatment) using biomechanical, functional and community participation \& quality of life metrics. The robotic exoskeletons being used in this study are the AtalanteX (Wandercraft), Ekso NR (Ekso Bionics), and Restore (Lifeward).

Conditions

• Hemiparesis After Stroke

Interventions

Type	Name	Description
DEVICE	Robotic Exoskeleton	EksoNR, Ekso Bionics, San Rafael, CA, USA Atalante X, Wandercraft, Paris, France ReStore™, Lifeward Inc, Marlborough, MA
OTHER	SOC	Standard of Care

Timeline

• Start date: 2025-05-15
• Primary completion: 2029-12-31
• Completion: 2030-06-01
• First posted: 2024-12-16
• Last updated: 2025-09-02

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study